Home Healthcare & Nursing Switzerland: 4.5–7× EBITDA, 3,232 Firms (2026)

1.0Market Snapshot

CHF 3.7B: Revenue of home-care (Spitex) providers in 2024: CHF 3.67 billion, BFS Spitex statistics (November 2025). For-profit providers grew their revenue by CHF 162 million (+22%), non-profit organisations by CHF 127 million (+5%).
3,232: Home-care providers in the BFS Spitex statistics 2024: 844 for-profit companies, 605 non-profit organisations and 1,783 independent nurses. About 130 new for-profit providers started in 2024.
50,447: Employees in nursing and home-care activities (NOGA 86.90.03) in 2024, BFS STATENT (31,394 full-time equivalents), up from 42,248 in 2021; 85.5% are women.
+10.2%: Growth of Spitex nursing hours in 2024, to 25.6 million — the largest increase since 2011 (BFS). For-profit providers grew their nursing hours by 23.4%.

According to Val Index analysis of Swiss commercial-register and federal data (2026), the Swiss home healthcare & nursing market is worth CHF 3.7B — Revenue of home-care (Spitex) providers in 2024: CHF 3.67 billion, BFS Spitex statistics (November 2025). For-profit providers grew their revenue by CHF 162 million (+22%), non-profit organisations by CHF 127 million (+5%)..

According to Val Index analysis of Swiss commercial-register and federal data (2026), Switzerland counts 3,232 home healthcare & nursing companies — Home-care providers in the BFS Spitex statistics 2024: 844 for-profit companies, 605 non-profit organisations and 1,783 independent nurses. About 130 new for-profit providers started in 2024..

2.0Industry Overview

Market Scope

Home care is the fastest-growing part of Swiss long-term care. According to the BFS Spitex statistics, about 424,000 clients received 25.6 million hours of nursing care at home in 2024 — 10.2% more than in 2023, the largest increase since 2011. Home-care providers earned CHF 3.67 billion. The market has three parts: 605 non-profit Spitex organisations, most with a public service mandate from their municipality; 844 for-profit companies; and 1,783 independent nurses. BFS business statistics (STATENT) count 50,447 employees in nursing and home-care activities in 2024, up from 42,248 in 2021.

3.0Industry Health Check (SWOT)

Internal factors

Strengths4

Record demand: 25.6 million nursing hours in 2024, +10.2% (BFS)

Weaknesses4

Staff costs dominate; nurses are scarce→ §5.0

External factors

Opportunities4

Ageing population and shorter hospital stays

Threats4

Regulation of family-caregiver employment models by cantons and insurers

Sector Outlook

DefensiveBalancedGrowth

4.0Key Trends

Record nursing hours

10.2%

Spitex providers delivered 25.6 million nursing hours to about 424,000 clients in 2024, 10.2% more than in 2023 — the largest increase since 2011 (BFS, November 2025). Revenue reached CHF 3.67 billion.

For-profit providers take the growth

23.4%

About 130 new for-profit providers started in 2024, bringing their number to 844. They grew nursing hours by 23.4%, clients by 20.5% and staff by 23.5%; revenue rose by CHF 162 million (+22%). Non-profit organisations served 2.5% fewer clients, the second decline in a row.

Family members as employed caregivers

47%

For-profit providers hired almost 3,700 people without specific care training in 2024, raising that group to 11,500 (+47%); the BFS assumes a significant part are relatives employed to care for family members. Cantons and insurers are debating how such care should be paid.

Mergers among public Spitex

Spitex Zürich Limmat and Spitex Zürich Sihl merged into Spitex Zürich AG, which has held a single city-wide service contract since January 2023. With 1,500 employees and more than 10,000 clients a year, it is the largest Spitex organisation in Switzerland; a new CEO takes over on 1 July 2026.

Private groups: a disputed deal

CHF 250 million

Tertianum agreed on 12 December 2025 to buy Senevita from the French Emeis group for about CHF 250 million; the Competition Commission approved it. On 9 April 2026 Emeis withdrew, citing a change in strategy. Tertianum sued at the Zurich Commercial Court and obtained a preliminary injunction that restricts changes at Senevita during the proceedings.

5.0Cost Structure Benchmark

78%

Personnel78%: nurses, care assistants, home help, coordination
Travel and vehicles5%
Materials and medical supplies4%
Administration and IT5%
Rent and other costs2%
EBITDA margin6%

Indicative split for a private Spitex company, not a measured figure: the BFS publishes Spitex revenue but not a cost structure by provider type. Personnel is by far the largest cost in home care; margins depend on the share of nursing care versus home help and on cantonal residual financing.

6.0Top Home Healthcare & Nursing Companies in Switzerland

Name	Location	Key Facts
Spitex ZürichCHE-196.449.241	Zürich ZH	Spitex Zürich AG: formed by the merger of Spitex Zürich Limmat and Spitex Zürich Sihl; single service contract with the City of Zurich since January 2023. 1,500 employees and more than 10,000 clients a year — the largest Spitex organisation in Switzerland. Manfred S. Hertach becomes CEO on 1 July 2026.
SenevitaCHE-106.450.247	Muri bei Bern BE	Senevita AG: nursing homes, assisted living and the private Spitex Senevita Casa, which grew out of the takeover of Spitex für Stadt und Land in 2016. Owned by the French Emeis group (formerly Orpea) since 2014; its agreed sale to Tertianum (December 2025, about CHF 250 million) was cancelled by Emeis in April 2026 and is being contested in court.

Spitex Zürich

CHE-196.449.241

Zürich ZH

Spitex Zürich AG: formed by the merger of Spitex Zürich Limmat and Spitex Zürich Sihl; single service contract with the City of Zurich since January 2023. 1,500 employees and more than 10,000 clients a year — the largest Spitex organisation in Switzerland. Manfred S. Hertach becomes CEO on 1 July 2026.

Senevita

CHE-106.450.247

Muri bei Bern BE

Senevita AG: nursing homes, assisted living and the private Spitex Senevita Casa, which grew out of the takeover of Spitex für Stadt und Land in 2016. Owned by the French Emeis group (formerly Orpea) since 2014; its agreed sale to Tertianum (December 2025, about CHF 250 million) was cancelled by Emeis in April 2026 and is being contested in court.

7.0Succession & M&A Context

Hundreds of new private firms — and a buyer market for the established ones

844: for-profit home-care providers in 2024, about 130 of them new (BFS)
CHF 3.7B: revenue of home-care providers in 2024 (BFS)
+10.2%: growth of Spitex nursing hours in 2024, the largest since 2011 (BFS)
4.5–7.0×: EBITDA deal multiples (ValIndex multiples table)

The home-care market is splitting. Non-profit Spitex organisations with public mandates merge into larger regional units, as in Zurich. For-profit providers multiply — 844 in 2024, about 130 of them new — and the fastest growth comes from models that employ family caregivers, which depend on how cantons and insurers treat them. For owners of established private Spitex firms, buyers are nursing-home groups adding home care, larger private providers and investors; a clean licence, trained nursing staff and a diversified client base matter more than size. The Tertianum–Senevita dispute shows that even signed deals can fail. ValIndex's multiples table puts home-healthcare providers at 4.5–7.0× EBITDA in transactions and 3.0–5.0× on statutory valuations.

Market Pulse

Unlock full Home Healthcare & Nursing intelligence

Market trends, cost structure, key players, succession analysis and regional clusters for Home Healthcare & Nursing — subscribe free to Market Pulse.

Free weekly newsletter. Unsubscribe anytime.

8.0Regional Clusters

Western Switzerland

VDGEFRVSNEJU

1,175 enterprises with 13,688 employees in 2024 (BFS STATENT, NOGA 86.90.03) — the largest region by employment. Vaud has 6,507 employees, Geneva 3,517.

Zurich

512 enterprises with 10,131 employees — 20 per enterprise, the largest units. Spitex Zürich AG alone has 1,500 employees.

Northwestern Switzerland

AGBLBS

326 enterprises with 7,218 employees; Basel-Stadt has 2,358 employees in 45 enterprises.

Bern and Solothurn

BESO

423 enterprises with 6,261 employees; Senevita is based in Muri bei Bern.

Eastern Switzerland

SGTGGRSHARAIGL

281 enterprises with 5,929 employees; St. Gallen has 2,926.

Central Switzerland

LUSZZGOWURNW

174 enterprises with 4,332 employees; Lucerne has 2,341.

Ticino

610 enterprises — 17% of the Swiss total — but only 2,888 employees: most are independent nurses and small firms.

Sources

BFS — Pflegestunden der Spitex-Dienste erreichten 2024 Rekordwerte (media release, 11 November 2025): 424,000 clients, 25.6m hours, 844 for-profit / 605 non-profit / 1,783 independent nurses, revenue CHF 3.67bn BFS — Hilfe und Pflege zu Hause (Spitex statistics)BFS STATENT — institutional units, employees and FTE by NOGA type and canton, 2011–2024 (NOGA 869003 nursing and home care)Medinside — Spitex Zürich erhält einen neuen CEO (December 2025): 1,500 employees, 10,000+ clients Medinside — Neuer Zusammenschluss: Spitex Zürich AG Tertianum — Senevita and Tertianum now under one roof (12 December 2025): agreement signed with Emeis, approved by COMCO SRF — Senevita-Eigentümer blasen Verkauf an Tertianum ab (10 April 2026): about CHF 250m, lawsuit and preliminary injunction Wikipedia — Senevita (Orpea/Emeis since 2014; takeover of Spitex für Stadt und Land in 2016)Medinside — Pro Senectute Zürich: Spitex vor dem Aus (12 September 2025)Zefix — Swiss Central Business Name Index (register entries of all key players)

Alain Walder, M.A. HSG · ValIndex|Data as of 2026-09|10 sources cited

Corrections

Figures and statements from the February 2026 edition that this edition withdraws or corrects, and why.

"CHF 4-5B market" replaced by the BFS Spitex statistics: CHF 3.67 billion of revenue in 2024.
"~2,500 providers (~600 public, ~1,900 private)" replaced by BFS 2024: 605 non-profit, 844 for-profit providers and 1,783 independent nurses. "~60,000 employees" replaced by BFS STATENT: 50,447.
"<1% export ratio", "~7% growth" and "~85% capacity utilisation" withdrawn: no source. Growth is now the BFS figure for nursing hours (+10.2% in 2024).
Senevita corrected: owned by the French Emeis group (formerly Orpea) since 2014, not by Aevis Victoria. "Spitex für Stadt und Land" is no longer a separate player: Senevita took it over in 2016.
Spitex Schweiz, ASPS, the Swiss Red Cross and Pro Senectute removed from the key players: they are associations and charities. Home Instead and CarePool removed: not confirmed.
The cost split is now labelled as indicative: it was never measured.

9.0Frequently Asked Questions

▶How much is a home-care (Spitex) company worth in Switzerland?

ValIndex's multiples table puts Swiss home-healthcare providers at 4.5–7.0× EBITDA in transactions and 3.0–5.0× EBITDA on statutory valuations. Buyers pay more for firms with trained nursing staff, a diversified client base and a clean cantonal licence, and less for firms whose revenue depends on a few family-caregiver arrangements or on residual financing that could change.

▶What drives the value of a private Spitex company?

Buyers price: (1) the cantonal licence and insurer contracts; (2) the share of nursing care (paid by basic insurance) versus home help; (3) trained nursing staff and turnover; (4) dependence on family-caregiver employment models; (5) cantonal residual financing; (6) client concentration and referral sources such as hospitals.

▶How big is the Swiss home-care market?

BFS Spitex statistics count about 424,000 clients, 25.6 million nursing hours and CHF 3.67 billion of revenue in 2024. Providers: 844 for-profit companies, 605 non-profit organisations and 1,783 independent nurses. BFS STATENT counts 50,447 employees in nursing and home-care activities.

▶Who are the main home-care providers in Switzerland?

The largest organisation is Spitex Zürich AG, with 1,500 employees and more than 10,000 clients a year. Most non-profit Spitex organisations are regional, with a municipal mandate. Among private groups, Senevita runs the private Spitex Senevita Casa; its sale to Tertianum was agreed in December 2025 and cancelled by the owner Emeis in April 2026, a decision Tertianum is contesting in court.

▶What are the key trends in Swiss home care?

Five trends: (1) record nursing hours, +10.2% in 2024; (2) for-profit providers take the growth — about 130 new firms in 2024; (3) employment of family members as caregivers; (4) mergers among public Spitex organisations, as in Zurich; (5) consolidation among private groups, including the disputed Tertianum–Senevita deal.

▶What are the main risks when buying a Swiss Spitex company?

The main risks are: (1) regulatory changes to family-caregiver models; (2) cantonal residual financing and public contributions, which led Pro Senectute Zürich to close its Spitex service; (3) nurse shortages; (4) licence and quality requirements; (5) transaction risk. Due diligence should check the licence, insurer contracts, staff qualifications and revenue by type of service.

▶Why are private Spitex providers growing so fast?

Because demand is rising and entry is open: any provider that meets the cantonal licence requirements can bill basic health insurance for nursing care. In 2024 for-profit providers grew nursing hours by 23.4%, partly by employing relatives who care for family members — almost 3,700 people without specific training were hired that year (BFS).

▶Where are Swiss home-care providers located?

Western Switzerland has the most home-care employment (13,688 employees in 1,175 enterprises in 2024), followed by Zurich (10,131 in 512), Northwestern Switzerland (7,218 in 326), Bern and Solothurn (6,261 in 423), Eastern Switzerland (5,929 in 281) and Central Switzerland (4,332 in 174). Ticino has 610 enterprises — mostly independent nurses — with 2,888 employees.

Home Healthcare & Nursing

Home Healthcare & Nursing business valuation in Switzerland